AUCTORES
Globalize your Research
Review Article | DOI: https://doi.org/10.31579/2690-8794/165
1 Departement of Clinical Pathology, Faculty of Medicine, Brawijaya University, Kota Malang, Jawa Timur 65145, Indonesia.
2 Department of Dermatology and Venereology, Faculty of Medicine, Brawijaya University, Kota Malang, Jawa Timur 65145, Indonesia.
3 Doctoral Program of Medical Science, Brawijaya University, Kota Malang, Jawa Timur 65145, Indonesia.
*Corresponding Author: Kusworini Handono, Dhelya Widasmara, Hani Susianti, Thigita A Pandaleke (2023), Orthosiphon Aristatus Alleviates Skin Barrier Through Cytokines Regulation in DNCB- Induced Atopic Dermatitis Balb/C Mice Model, Clinical Medical Reviews and Reports, 5(3); DO
Citation: Kusworini Handono, Dhelya Widasmara, Hani Susianti, Thigita A Pandaleke (2023), Orthosiphon Aristatus Alleviates Skin Barrier Through Cytokines Regulation in DNCB- Induced Atopic Dermatitis Balb/C Mice Model, Clinical Medical Reviews and Reports, 5(4); DOI:10.31579/2690-8794/165
Copyright: Kusworini Handono, Dhelya Widasmara, Hani Susianti, Thigita A Pandaleke (2023), Orthosiphon Aristatus Alleviates Skin Barrier Through Cytokines Regulation in DNCB- Induced Atopic Dermatitis Balb/C Mice Model, Clinical Medical Reviews and Reports, 5(3); DOI:10.31579/2690-8794/165
Received: 05 June 2023 | Accepted: 22 June 2023 | Published: 30 June 2023
Keywords: orthosiphon aristatus; atopic dermatitis; 2,4-dinitrochlorobenzene; IgE; IL4; IL22; PGE2; NO
Background: to analysed the effect of Orthosiphon aristatus on repairing skin lesions by regulating cytokines such as IgE, IL4, IL22, PGE2, NO in DNCB-induced Atopic Dermatitis BALB/C Mice Model
Methods: used BALB/C Mice which were sensitized by DNCB for 21 days to developed atopic dermatitis model. Mice were administered oral Orthosiphon aristatus extract once daily (on last 14 days after 7 days of sensitization). The doses given were divided into 6 groups: 17.5 mg/kgbw, 35 mg/kgbw, 70 mg/kgbw, and 140 mg/kgbw. We analysed the levels of cytokines such as IgE, IL4, IL22, PGE2 obtained from the blood. Additionally, we also measured morphological skin lesion severity to confirmed the amelioration effect clinically.
Results: Administration of Orthosiphon aristatus extract reduced the skin lesion severity in all intervention groups. The clinical improvement was supported by decrease of IgE, IL4, IL22, and PGE2 in dose dependent manner.
Conclusion: Orthosiphon aristatus alleviates DNCB-induced Atopic Dermatitis BALB/C Mice Model clinically through downregulating of IgE, IL4, IL22, PGE2, NO levels.
Atopic Dermatitis (AD) is a chronic skin inflammation, recurrent, characterized by itching, arising in certain predilection sites, and associated with other atopic diseases such as allergic rhinitis and asthma. The clinical manifestations of AD are primarily characterized by pruritus, erythematous lesions in acute and lichenification in chronic state, and dry skin. Itch-scratch cycle in AD also triggers secondary infection [1]. The etiology of atopic dermatitis is not fully understood. It might be multifactorial, such as genetic, destruction of skin barrier, immunological, environment like food and aeroallergen. All of those induce a pathological pathway including inflammation and oxidative stress [2].
Atopic dermatitis begins with the destruction of the skin barrier. Destruction to the skin barrier causes increased production of keratinocyte cytokines such as Thymic Stromal Lymphoprotein (TLSP), IL33, IL1, IL6, IL8, and TNFα. These cytokines are able to stimulate formation of Th2, secrete IL4, IL13, and IL5, and produce IgE by B cells, increasing the expression of endothelial cell adhesion molecules, and eosinophil cell proliferation [3, 4]. Increase of IgE serum levels were found in the majority of AD cases and has a significant relationship with severity of AD [5]. Therefore, IgE is one of the criteria for diagnosing AD [3, 4]. In addition, Th2 and IL22 cells were reported to be involved in the inflammatory mechanism in AD. The cytokine IL22 is reported to cause epidermal hyperplasia and inhibit keratinocyte differentiation and filaggrin formation. Fillaggrin plays a role in the formation of Natural Moisturizing Factor (NMF) which keeps the skin moist. Interestingly, IL22 production is influenced by prostaglandin secretion. Previous studies reported an increase in Prostaglandin (PG) D2 and PGE2 in AD lesions followed by an increase in IL22 production [6, 7]. Robb et al (2018) showed that the DNCB-sensitized DA rats’ model had EP4 deficiency and increased IL22 production by T cells in lymph nodes [8]. PGD2 is major prostanoid produced by activated mast cells. The binding of PGD2 to the CTH2 receptor induces chemotaxis of Th2 cells, eosinophils, and basophils which exacerbates the inflammatory process in AD [6]. In addition to the inflammatory process, oxidative stress also plays a role in the mechanism of AD. ROS and NOS which increase either acutely or chronically cause damage to keratinocytes through the destruction of DNA, enzymes and cell membrane structures, thereby reducing the integrity of the skin barrier. Apart from originating from environmental free radicals, oxidative stress is also generated through inflammatory processes. During the inflammatory process, inflammatory cells such as macrophages secrete pro-inflammatory cytokines and nitric oxide (NO) [9, 10]. Therefore, nitric oxide (NO) is an important parameter of skin damage due to oxidative stress and inflammation in AD patients. Based on these mechanisms it can be concluded that effective therapy in AD is by repairing the skin barrier, inhibiting the inflammatory process, and reducing oxidative stress.
Therapeutic modalities currently available are systemic, topical, or phototherapy. The main purposes of the therapy are reduced the severity, prevent infection, and control in long term. Pharmacological therapy includes corticosteroids to treat inflammation, antibiotics for bacterial infections, antihistamines for pruritic symptoms, and calcineurin inhibitors to prevent the spread of eczema and reduce inflammation. Additionally, immunomodulation and phototherapy also been reported to have significant therapeutic effect [11, 12]. Long-term use of systemic corticosteroids in AD patients can cause side effects such as metabolic (hyperglycemia, hypertension, hyperlipidemia), gastrointestinal (gastric ulcers, gastritis, pancreatitis, ulcerative colitis), and Cushing's syndrome. Meanwhile, topical corticosteroids can have side effects on the skin such as skin atrophy, striae, purpura, telangiectasia, hypertrichosis, hypopigmentation, acneiform eruptions, and perioral dermatitis [1]. Antimetabolite groups such as mycophenolate mofetil, azathioprine can cause myelosuppression, especially in elderly users and those with kidney disorders, besides that, antimetabolite groups are also not recommended for use in pregnant women (Category D) [1]. Therapies that are currently being developed such as biologic agents have good effects but are expensive and require multiple injections, making them difficult to give to pediatric patients, and are less curative [13]. Therefore, there is demand of therapeutic modalities with minimal side effects and cost effectiveness, such as the use of bioactive compound from nature like Orthosiphon aristatus. Orthosiphon aristatus has antioxidant and anti-inflammatory activity which is played by phenolics, flavonoids, diterpenes, triterpenes [14, 15]. An in vitro study on murine macrophages conducted by Laavaola et al reported that the chloroform extract from Orthosiphon aristatus leaves, especially the eupatorine and sinestein contents, inhibited iNOS expression and reduced NO and PGE2 production, thereby reducing IL22 levels produced by Th cells [16]. Orthosiphon aristatus ethanol extract and its bioactive compounds (ursolic acid) has the most prominent inhibitory ability by suppressing LPS-induced production of NO and prostaglandin E2 (PGE2) by inhibiting ROS formation while reducing iNOS and COX2 expression in RAW 264.7 cells [17]. Therefore, Orthosiphon aristatus is a potential candidate for effective atopic dermatitis therapy with minimal side effects and cost effectiveness. This study uses Orthosiphon aristatus as an intervention for therapy of DNCB-induced atopic dermatitis BALB/c mice model. This study showed the clinical symptoms of AD pre and post intervention, and analszed serum IgE, NO, IL4, IL22, PGE2, and NO levels as parameters of atopic dermatitis. Additionally, this is the first study that observed the effect of Orthosiphon aristatus in atopic dermatitis.
Methods
Animals and experimental design
This research was conducted at the research and animal handling laboratory, Brawijaya University, Malang. This study used 36 BALB/C mice (aged 6 weeks) with 15–20 grams in weight. This model adopted a previous study (Son et al., 2019) which used 2,4 dinitrochlorobenzene (DNCB) to sensitize and made an atopic dermatitis model. Mice was maintained in a cage with room temperature (22 ± 20C), 40–60% of humidity for acclimatization in a week. They were maintained with food and drink ad libitum with a 12:12 hour dark-light cycle. After a week of acclimatization, their back hair was shaved and started to sensitize the skin with 200 µL of DNCB 1
Atopic disease like atopic dermatitis is a chronic inflammatory skin disease associated with other atopic diseases such as allergic rhinitis and asthma [19–22]. It is a genetic predisposition disease and common in pediatric patients. was frequently associated with food allergy at least in 40% of children [23]. The clinical manifestations of AD are primarily characterized by pruritus, erythematous lesions in acute and lichenification in chronic state, also dry skin [1]. Previous study showed that AD patient had sleep disturbance and depression, and also affect the quality of life of patients [18]. This study confirmed that skin lesion severity in positive control was worse than negative control significantly. These symptoms include erythema, hemorrhage, edema, excoriation/erosion, and scaling/dryness. Interestingly, these symptoms were alleviated with administration of Orthosiphon aristatus leaves extract. This study showed that skin lesion was healed after extract administration in dose dependent manner (Fig. 1). Additionally, this study analyzed serum markers to confirmed that beneficial effect of Orthosiphon aristate give impact in molecular level. Therefore, we measured serum levels of IgE, IL22, IL4, PGE2, and NO. These molecules had known play roles in atopic dermatitis pathophysiology.
The etiology of atopic dermatitis is not fully understood. It might be affected by multifactorial, such as genetic, destruction of skin barrier, immunological, environment like food and aeroallergen [2]. All of these risks cause skin barrier destruction through inflammation reaction and oxidative stress. These reactions increase production of keratinocyte cytokines such as TLSP, IL33, IL1, IL6, IL8, and TNFα, which are able to stimulate the formation of Th2, secretes IL4, IL13, and IL5. Additionally, Th2 stimulates B cells to secrete IgE antibodies, which increase expression of endothelial cell adhesion molecules, and eosinophil cell proliferation [3, 4]. On the other hand, inflammation involves hypersensitivity reactions associated with allergens. Furthermore, production of IgE and histamine are closely associated with this mechanism and become one of the diagnostic criteria of AD [3, 4, 21, 22]. In addition, IL22 plays a role in the inflammation reaction of AD. This cytokine causes epidermal hyperplasia and inhibits keratinocyte differentiation and filaggrin formation which disturbs skin moisturizing [6]. Interestingly, IL22 production is influenced by prostaglandin secretion. Previous studies reported an increase in Prostaglandin (PG) D2 and PGE2 in AD lesions followed by an increase in IL22 production [6, 7]. A study showed that the DNCB-sensitized AD rats’ model had EP4 deficiency and increased IL22 production by T cells in lymph nodes. PGD2 is the main proteinoid produced by activated mast cells. Its binding to the CTH2 receptor also induces chemotaxis of several immune cells which exacerbates AD inflammation process [6]. This study showed increase of IgE, IL4, IL22, PGE2, and NO levels in BALB/C mice after DNCB sensitizing-induced atopic dermatitis.
Currently, steroids, antihistamines, and immunosuppressives are commonly used to treat AD, but side effects often occur [24]. Recently, complementary and supportive therapy like herbal medicine, have been reported more frequently and globally. Although evidences are limited, some herbal medicines administered topically and orally effective for treating AD [25]. Orthosiphon aristatus leaves extract is one of important herbal medicines. Previous studies reported that more than 20 phenolic compounds were detected from Orthosiphon aristatus leaves, and the compounds that have pharmacological properties include caffeic acid, rosmarinic acid, sinensetin, eupatorium, and polymethoxylated flavones [14, 26]. Beneficial effects of phenolic compounds in Orthosiphon aristatus includes antioxidant [27], antibacterial [28], antifungal [29], antidiabetic [30], antiinflammatory [17], antimutagenic [31], and antiarthritic [32].
This study is the first study that confirmed beneficial effects of administration Orthosiphon aristatus in atopic dermatitis. This study showed that administration of the Orthosiphon aristatus leaves extract reduced IgE, IL4, IL22, PGE2, NO serum levels. It was parallel with improvement of the skin lesions. It reflected that this extract improved the inflammation and oxidative stress that induced AD. Anti-inflammatory effects of Orthisiphon aristatus extract have been found in previous studies. A study used a 200µg extract and showed the inhibitory effect of TPA (tetradecanoylphorbol)-induced inflammation in mice [33]. A series of experiments showed that Orthisiphon aristatus extract reduced NO production in LPS activated macrophage-like J774.1 cells. Lyckander and Malterud (1992) showed the effect of ethyl acetate from extract and 8 lipophilic flavonoids isolated from Orthosiphon aristatus (leaves) on the arachidonic acid oxidation catalyzed by 15-lipoxygenase [34]. The results showed inhibition effect on 15-lipoxygenase [IC50 value amounting to 0.018% (w/v)] in dose-dependent inhibition manner compared to quercetin (positive control). Additionally, Orthosiphon aristatus showed antioxidant activity based on β-carotene coupled and autooxidised linoleic acid mechanism and were comparable to quercetin and butylated hydroxyanisole [35]. Another study also marked inhibition mechanism of NO, PGE2, and ROS production, including iNOS and COX-2 gene expression in LPS-stimulated RAW 264.7 cells [17]. Even though, further research is still needed to assess the beneficial activity of this extract to control atopic dermatitis. Histological studies may be proposed to assess the degree of improvement at the microscopic structural level. Related to the role of Orthosiphon aristatus extract as atopic dermatitis therapy, both as supporting/adjuvant therapy, still needs further discussion.
Conclusion
We firstly reported the therapeutic effects of Orthosiphon aristatus leaf effect on atopic dermatitis by DNCB-induced AD-like lesion mouse models. Administration of Orthosiphon aristatus extract improved the progression of AD-like lesions severity. Additionally, it was demonstrated that the anti-atopic effects were exerted through down-regulating the serum level of cytokines such as IL4, IL22, IgE, PGE2, and NO. These effects suggested that Orthosiphon aristatus could be a valuable herbal therapy for atopic dermatitis.
Abbreviations
AD- atopic dermatitis
DNCB- 2,4 Dinitrochlorobenzene
IgE- immunoglobulin E
IL- Interleuikin
Inos- Inducible nitric oxide synthase
LPS- Lipopolysaccharides
NO- nitric oxide
NOS- nitrogen oxygen species
PGE- prostaglandin E
ROS- reactive oxygen species
Th- T-helper
TNF- tumor necrosis factor
TPA- tetradecanoylphorbol
TSLP- Thymic Stromal Lymphoprotein
Declarations
Availability of data and materials
The datasets generated during and/or analysed during the current study are available in Figshare: Dataset of Orthosiphon aristatus effect on DNCB-induced Atopic Dermatitis Mice Model. https://doi.org/10.6084/m9.figshare.22776173.
Acknowledgements
Not applicable
Ethics approval and consent to participate
All procedures performed in this experimental study involving animals were approved by the ethical committee of Faculty of Medicine, Brawijaya University with registration number 102-KEP-UB-2021
Consent for publication
Not applicable.
Competing interests
The authors have no confict of interest to declare.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
